Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$645M |
| 2 |
T-Mobile US
TMUS
|
+$640M |
| 3 |
AT&T
T
|
+$517M |
| 4 |
Humana
HUM
|
+$481M |
| 5 |
Boston Scientific
BSX
|
+$400M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$755M |
| 3 |
Meta Platforms (Facebook)
META
|
+$707M |
| 4 |
Caterpillar
CAT
|
+$472M |
| 5 |
Advanced Micro Devices
AMD
|
+$449M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.33% |
| 2 | Technology | 3.2% |
| 3 | Financials | 2.22% |
| 4 | Industrials | 2.17% |
| 5 | Consumer Discretionary | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6201
PUT
Pliant Therapeutics
PLRX
$66.3M
| $1.27M | ﹤0.01% |
47,600
+13,700
| +40% | +$390K |
|
|
MRNS
6202
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $1.27M | ﹤0.01% |
183,408
-169,045
| -48% | -$1.06M |
|
6203
PUT
QuidelOrtho
QDEL
$981M
| $1.27M | ﹤0.01% |
14,200
-53,300
| -79% | -$4.64M |
|
6204
AZZ Inc
AZZ
$4.55B
| $1.26M | ﹤0.01% |
30,672
+3,307
| +12% | +$136K |
|
|
BPMC
6205
PUT
DELISTED
Blueprint Medicines
BPMC
| $1.26M | ﹤0.01% |
28,100
-14,800
| -34% | -$667K |
|
6206
CALL
Designer Brands
DBI
$299M
| $1.26M | ﹤0.01% |
144,500
+76,600
| +113% | +$735K |
|
6207
Vanguard Consumer Staples ETF
VDC
$7.93B
| $1.26M | ﹤0.01% |
6,526
+2,687
| +70% | +$509K |
|
6208
CALL
Vanguard FTSE All-World ex-US ETF
VEU
$70.8B
| $1.26M | ﹤0.01% |
23,600
+11,600
| +97% | +$615K |
|
|
LONA
6209
LeonaBio Inc
LONA
$74.8M
| $1.26M | ﹤0.01% |
50,436
-7,951
| -14% | -$256K |
|
6210
Pacer Trendpilot European Index ETF
PTEU
$38.2M
| $1.26M | ﹤0.01% |
48,643
-25,090
| -34% | -$629K |
|
6211
PUT
PTC Therapeutics
PTCT
$6.08B
| $1.26M | ﹤0.01% |
26,000
+23,500
| +940% | +$1.07M |
|
6212
Central Garden & Pet Co
CENT
$2.74B
| $1.26M | ﹤0.01% |
38,334
+11,500
| +43% | +$372K |
|
6213
PUT
Qfin Holdings
QFIN
$1.45B
| $1.26M | ﹤0.01% |
64,900
+4,200
| +7% | +$88K |
|
6214
SES AI
SES
$211M
| $1.26M | ﹤0.01% |
426,651
+425,124
| +27,840% | +$1.34M |
|
|
VRTV
6215
CALL
DELISTED
VERITIV CORPORATION
VRTV
| $1.26M | ﹤0.01% |
9,300
+4,800
| +107% | +$615K |
|
|
ULTR
6216
DELISTED
IQ Ultra Short Duration ETF
ULTR
| $1.26M | ﹤0.01% |
26,450
+17,690
| +202% | +$842K |
|
6217
Goldman Sachs Access Ultra Short Bond ETF
GSST
$1.6B
| $1.25M | ﹤0.01% |
25,130
+18,302
| +268% | +$912K |
|
6218
Xtrackers S&P 500 ESG ETF
SNPE
$2.95B
| $1.25M | ﹤0.01% |
+33,742
| New | +$1.22M |
|
6219
iShares MSCI Netherlands ETF
EWN
$733M
| $1.25M | ﹤0.01% |
29,732
+20,426
| +219% | +$842K |
|
6220
PUT
Cerence
CRNC
$385M
| $1.25M | ﹤0.01% |
44,600
+29,000
| +186% | +$745K |
|
|
HIMX
6221
PUT
Himax Technologies
HIMX
$2.69B
| $1.25M | ﹤0.01% |
154,000
-158,500
| -51% | -$1.22M |
|
6222
CALL
Schwab U.S Small- Cap ETF
SCHA
$23.8B
| $1.25M | ﹤0.01% |
59,600
+16,400
| +38% | +$352K |
|
6223
Sundial Growers
SNDL
$306M
| $1.25M | ﹤0.01% |
780,610
+740,687
| +1,855% | +$1.45M |
|
6224
CALL
Leslie's
LESL
$6.14M
| $1.25M | ﹤0.01% |
5,670
-1,500
| -21% | -$390K |
|
6225
CALL
Carriage Services
CSV
$579M
| $1.25M | ﹤0.01% |
40,900
+20,200
| +98% | +$641K |
|
Similar funds
Ken Griffin's Q1 2023 Portfolio in Review
As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.
- Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
- Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
- Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
- Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
- Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
- Ken Griffin opened 1,466 new positions and closed 1,652 in Q1 2023.
- Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.
Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.